Inhibition of proliferative vitreoretinopathy by a newly developed methotrexate loaded drug carrier in vitro.

Autor: Arrow SS; Department of Ophthalmology, University Hospital Ulm, Prittwitzstraße 43, 89075 Ulm, Germany. Electronic address: sebastian.arrow@uniklinik-ulm.de., Felis SC; Department of Ophthalmology, University Hospital Ulm, Prittwitzstraße 43, 89075 Ulm, Germany., Hillenmayer A; Department of Ophthalmology, University Hospital Ulm, Prittwitzstraße 43, 89075 Ulm, Germany., Strehle LD; Department of Ophthalmology, University Hospital Ulm, Prittwitzstraße 43, 89075 Ulm, Germany., Koenig SF; Department of Ophthalmology, University Hospital Ulm, Prittwitzstraße 43, 89075 Ulm, Germany., Vounotrypidis E; Department of Ophthalmology, University Hospital Ulm, Prittwitzstraße 43, 89075 Ulm, Germany., Wolf A; Department of Ophthalmology, University Hospital Ulm, Prittwitzstraße 43, 89075 Ulm, Germany., Wertheimer CM; Department of Ophthalmology, University Hospital Ulm, Prittwitzstraße 43, 89075 Ulm, Germany.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Feb; Vol. 158, pp. 114088. Date of Electronic Publication: 2022 Dec 08.